Shares of Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU – Get Free Report) were down 0.6% during trading on Thursday . The company traded as low as $10.49 and last traded at $10.49. Approximately 53 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 31,147 shares. The stock had previously closed at $10.55.
Drugs Made in America Acquisition Trading Down 0.6%
The company has a fifty day moving average price of $10.49 and a two-hundred day moving average price of $10.48.
About Drugs Made in America Acquisition
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
Further Reading
- Five stocks we like better than Drugs Made in America Acquisition
- 10 Best Airline Stocks to Buy
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- How to Capture the Benefits of Dividend Increases
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Receive News & Ratings for Drugs Made in America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
